Stock exchange and press releases of BBS will be published on these pages. Releases are published in Finnish and in English.
Contact information for the media: info@bbs-artebone.fi from which you can also request additional media material
Archived releases can be found:
2018
2019
2020
2021
19.11.2021 BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS-Bioactive Bone Substitutes Plc ja Riverfort Global Opportunities PCC Ltd
17.11.2021 BBS-Bioactive Bone Substitutes Plc: Claims of the patent application for the manufacturing of the ARTEBONE® product have been approved in the USA
30.09.2021 BBS-Bioactive Bone Substitutes Plc has agreed on a capital facility to strengthen the company's working capital – further enables the CE marking application
07.09.2021 BBS-Bioactive Bone Substitutes Plc: Animal test results completed contributing on their part to submitting the CE marking application
25.08.2021 BBS-Bioactive Bone Substitutes Plc: CORRECTION: Half-Year Report January 1st –June 30th 2021 (Unaudited)
25.08.2021 BBS-Bioactive Bone Substitutes Plc: Half-Year Report January 1st –June 30th 2021 (Unaudited)
29.04.2021 BBS-Bioactive Bone Substitutes Plc - CORRECTION: Decisions of the Annual General Meeting 2021
28.04.2021 BBS-Bioactive Bone Substitutes Plc: Decisions of the Annual General Meeting 2021
26.04.2021 BBS-Bioactive Bone Substitutes Plc: Submission of CE marking application for ARTEBONE® products moves to August
08.04.2021 BBS-Bioactive Bone Substitutes Plc: CORRECTION TO THE INVITATION TO THE ANNUAL GENERAL MEETING